Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 07, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons in the company's Ordinary Shares, specifically detailing movements within the GlaxoSmithKline Employee Trust ("GSK Trust").
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share transaction volumes and a specific sale price.
- Share Sale Price: GBP 15.01 per Ordinary Share (for shares sold on behalf of participants).
- Share Transfers: Total of 67,776 Ordinary Shares transferred or sold by the GSK Trust to plan participants during the reporting window.
Material Changes
The filing does not report material changes to the company's financial position or operations compared to prior periods. It details routine administrative transactions related to employee share plans:
- April 4, 2006: 30,622 shares transferred to SmithKline Beecham Employee Share Option Plan 1991 participants.
- April 5, 2006: 6,252 shares transferred to SmithKline Beecham Employee Share Option Plan 1991 participants.
- April 5, 2006: 30,902 shares transferred to GlaxoSmithKline Share Value Plan participants.
- April 5, 2006: 7,196 shares sold on behalf of GlaxoSmithKline Share Value Plan participants.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) are interested in shares held in the GSK Trust in the same capacity as other employees. The transactions were notified in accordance with Disclosure Rule 3.1.4R(1)(b).
Investor Verification Checklist
- Verify the total number of shares transferred to employee plans (67,776 shares) against internal cap table records.
- Confirm the execution price of GBP 15.01 aligns with market prices on April 5, 2006.
- Review the specific terms of the SmithKline Beecham Employee Share Option Plan 1991 and the GlaxoSmithKline Share Value Plan to understand vesting or exercise conditions.
- Check for any subsequent filings regarding the directors' direct holdings versus their indirect interest through the GSK Trust.